Global human fibrin glue market is projected to register a CAGR of 9.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation:
Global America Human Fibrin Glue Market, By Form (Liquid, Patch, Others), Application (Cardiac Surgery, Pulmonary Surgery, Burn Bleeding, Vascular Surgeries, Orthopedic Surgeries, Lacerations of liver and Spleen, Neurosurgery, Plastic Surgery, General Surgery, Wound Management, others), Distribution Channel (Direct Tender and Retail Sales), End User (Hospitals, Ambulatory Care Centers, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of the Middle East and Africa, Brazil, Argentina and Rest of South America) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the global human fibrin glue market are:
Introduction of innovative and technology products and rising disposable income
Increasing number of surgeries
Market Players:
The key market players for global human fibrin glue market are listed below:
Johnson & Johnson Services, Inc.
Baxter
CSL Limited
Corza Health
Shanghai RAAS
Marquee Biosurgical
Hualan Biological Engineering, Inc
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 OVERVIEW OF GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET 21
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 23
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
2.6 MULTIVARIATE MODELLING 31
2.7 PACKAGE FORM LIFELINE CURVE 32
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.9 DBMR MARKET POSITION GRID 34
2.10 MARKET APPLICATION COVERAGE GRID 35
2.11 VENDOR SHARE ANALYSIS 36
2.12 SECONDARY SOURCES 37
2.13 ASSUMPTIONS 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 40
5 INDUSTRY INSIGHTS 41
6 REGULATORY ANALYSIS 42
6.1.1 REGULATION IN U.S. 42
6.1.2 REGULATION IN EUROPE 43
6.1.3 REGULATION IN AUSTRALIA 43
6.1.4 REGULATION IN CANADA 44
6.1.5 REGULATION IN CHINA 44
7 MARKET OVERVIEW 45
7.1 DRIVERS 47
7.1.1 INCREASE IN TECHNOLOGICAL ADVANCEMENT 47
7.1.2 INCREASING SURGICAL PROCEDURES 47
7.1.3 ADVANTAGES OF HUMAN FIBRIN GLUE 48
7.1.4 INCREASE IN THE GERIATRIC POPULATION 48
7.1.5 SUPERIORITY OF FIBRIN SEALANTS, OVER LIMITATIONS OF CONVENTIONAL METHODS 49
7.2 RESTRAINTS 49
7.2.1 STRINGENT RULES & REGULATORY 49
7.2.2 HIGH COST OF PRODUCTS 50
7.2.3 RISK OF VIRAL INFECTIONS 50
7.3 OPPORTUNITIES 50
7.3.1 INCREASE IN PREVALENCE OF CHRONIC DISORDERS 50
7.3.2 RISE IN MINIMALLY INVASIVE SURGERIES 51
7.3.3 RISING PLASTIC SURGERIES 51
7.4 CHALLENGES 52
7.4.1 COMPLICATION RELATED TO USE OF HUMAN FIBRIN GLUE 52
7.4.2 LACK OF SKILLED PROFESSIONALS 52
7.4.3 DECREASED SURGICAL PROCEDURES DUE TO COVID-19 53
8 IMPACT OF COVID-19 ON GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET 54
8.1 IMPACT ON PRICE 54
8.2 IMPACT ON SUPPLY CHAIN 54
8.3 IMPACT ON DEMAND 55
8.4 CONCLUSION 55
9 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM 56
9.1 OVERVIEW 57
9.2 LIQUID 60
9.2.1 1-2 ML 61
9.2.2 7-10 ML 61
9.2.3 3-4 ML 61
9.2.4 5-6 ML 61
9.3 PATCH 61
9.4 OTHERS 62
10 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER 63
10.1 OVERVIEW 64
10.2 HOSPITALS 67
10.3 SPECIALTY CLINICS 67
10.4 AMBULATORY CARE CENTER 68
10.5 OTHERS 69
11 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL 70
11.1 OVERVIEW 71
11.2 DIRECT TENDER 74
11.3 RETAIL SALES 74
12 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION 76
12.1 OVERVIEW 77
12.2 WOUND MANAGEMENT 80
12.3 BURN BLEEDING 80
12.4 PLASTIC SURGERY 81
12.5 GENERAL SURGERY 82
12.6 VASCULAR SURGERIES 82
12.7 LACERATIONS OF LIVER AND SPLEEN 83
12.8 CARDIAC SURGERY 84
12.9 PULMONARY SURGERY 84
12.10 ORTHOPEDIC SURGERIES 85
12.11 NEUROSURGERY 86
12.12 OTHERS 86
13 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION 88
13.1 OVERVIEW 89
13.2 NORTH AMERICA 94
13.2.1 U.S. 100
13.2.2 CANADA 102
13.2.3 MEXICO 104
13.3 EUROPE 106
13.3.1 GERMANY 112
13.3.2 U.K. 114
13.3.3 FRANCE 116
13.3.4 ITALY 118
13.3.5 SPAIN 120
13.3.6 SWITZERLAND 122
13.3.7 RUSSIA 124
13.3.8 NETHERLANDS 126
13.3.9 TURKEY 128
13.3.10 BELGIUM 130
13.3.11 REST OF EUROPE 132
13.4 ASIA-PACIFIC 133
13.4.1 CHINA 139
13.4.2 INDIA 141
13.4.3 JAPAN 143
13.4.4 SOUTH KOREA 145
13.4.5 AUSTRALIA 147
13.4.6 THAILAND 149
13.4.7 MALAYSIA 151
13.4.8 SINGAPORE 153
13.4.9 INDONESIA 155
13.4.10 REST OF ASIA-PACIFIC 157
13.5 SOUTH AMERICA 158
13.5.1 BRAZIL 164
13.5.2 ARGENTINA 166
13.5.3 REST OF SOUTH AMERICA 168
13.6 MIDDLE EAST & AFRICA 169
13.6.1 SAUDI ARABIA 175
13.6.2 SOUTH AFRICA 177
13.6.3 U.A.E 179
13.6.4 ISRAEL 181
13.6.5 EGYPT 183
13.6.6 REST OF MIDDLE EAST AND AFRICA 185
14 GLOBAL HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY LANDSCAPE 186
14.1 COMPANY SHARE ANALYSIS: GLOBAL 186
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 187
14.3 COMPANY SHARE ANALYSIS: EUROPE 188
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 189
15 SWOT ANALYSIS 190
16 COMPANY PROFILE 191
16.1 CSL LIMITED 191
16.1.1 COMPANY SNAPSHOT 191
16.1.2 REVENUE ANALYSIS 191
16.1.3 COMPANY SHARE ANALYSIS 192
16.1.4 PRODUCT PORTFOLIO 192
16.1.5 RECENT DEVELOPMENT 192
16.2 JOHNSON & JOHNSON SERVICES, INC. 193
16.2.1 COMPANY SNAPSHOT 193
16.2.2 REVENUE ANALYSIS 193
16.2.3 COMPANY SHARE ANALYSIS 194
16.2.4 PRODUCT PORTFOLIO 194
16.2.5 RECENT DEVELOPMENT 194
16.3 BAXTER 195
16.3.1 COMPANY SNAPSHOT 195
16.3.2 REVENUE ANALYSIS 195
16.3.3 COMPANY SHARE ANALYSIS 196
16.3.4 PRODUCT PORTFOLIO 196
16.3.5 RECENT DEVELOPMENTS 196
16.4 HUALAN BIOLOGICAL ENGINEERING, ING 197
16.4.1 COMPANY SNAPSHOT 197
16.4.2 COMPANY SHARE ANALYSIS 197
16.4.3 PRODUCT PORTFOLIO 197
16.4.4 RECENT DEVELOPMENT 197
16.5 SHANGHAI RAAS 198
16.5.1 COMPANY SNAPSHOT 198
16.5.2 COMPANY SHARE ANALYSIS 198
16.5.3 PRODUCT PORTFOLIO 198
16.5.4 RECENT DEVELOPMENT 199
16.6 CORZA HEALTH 200
16.6.1 COMPANY SNAPSHOT 200
16.6.2 PRODUCT PORTFOLIO 200
16.6.3 RECENT DEVELOPMENT 200
16.7 MARQUEE BIOSURGICAL 201
16.7.1 COMPANY SNAPSHOT 201
16.7.2 PRODUCT PORTFOLIO 201
16.7.3 RECENT DEVELOPMENT 201
17 QUESTIONNAIRE 202
18 RELATED REPORTS 205
Segmentation
Short Description
Global Human Fibrin Glue Market, By Form (Liquid, Patch, Others), Application (Cardiac Surgery, Pulmonary Surgery, Burn Bleeding, Vascular Surgeries, Orthopedic Surgeries, Lacerations of liver and Spleen, Neurosurgery, Plastic Surgery, General Surgery, Wound Management, others), Distribution Channel (Direct Tender and Retail Sales), End User (Hospitals, Ambulatory Care Centers, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of the Middle East and Africa, Brazil, Argentina and Rest of South America) Industry Trends and Forecast to 2029
Market Definition:
Fibrin glue is a topical biological adhesive, the effect of which imitates the final stages of coagulation. The glue consists of a solution of concentrated human fibrinogen which is activated by the addition of bovine thrombin and calcium chloride. These are used in various application such as general surgery, plastic surgery, neurology and vascular surgeries.
Market Segmentation:
Human fibrin glue market is categorized into four notable segments, based on package form, application, end user and distribution channel.
On the basis of package form, the human fibrin glue market is segmented into liquid, patch, and others
On the basis of application, the human fibrin glue market is segmented into cardiac surgery, pulmonary surgery, burn bleeding, vascular surgeries, orthopedic surgeries, lacerations of liver and spleen, neurosurgery, plastic surgery, general surgery, wound management, and others
On the basis of end user, the human fibrin glue market is segmented into hospitals, ambulatory care centre, speciality clinics, and others
On the basis of distribution channel, the human fibrin glue market is segmented into direct tender and retail sales
Market Players
The key market players for global human fibrin glue market are listed below:
Johnson & Johnson Services, Inc.
Baxter
CSL Limited
Corza Health
Shanghai RAAS
Marquee Biosurgical
Hualan Biological Engineering, Inc
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
